ABSTRACT
Background Although it is known that variation in the aldehyde dehydrogenase 2 (ALDH2) gene family influences the East Asian alcohol flushing response, knowledge about other genetic variants that affect flushing symptoms is limited.
Methods We performed a genome-wide association study meta-analysis and heritability analysis of alcohol flushing in 15,105 males of East Asian ancestry (Koreans and Chinese) to identify genetic associations with alcohol flushing. We also evaluated whether self-reported flushing can be used as an instrumental variable for alcohol intake.
Results We identified variants in the region of ALDH2 strongly associated with alcohol flushing, replicating previous studies conducted in East Asian populations. Additionally, we identified variants in the alcohol dehydrogenase 1B (ADH1B) gene region associated with alcohol flushing. Several novel variants were identified after adjustment for the lead variants (ALDH2-rs671 and ADH1B-rs1229984), which need to be confirmed in larger studies. The estimated SNP-heritability on the liability scale was 13% (S.E. = 4%) for flushing, but the heritability estimate decreased to 6% (S.E. = 4%) when the effects of the lead variants were controlled for. Genetic instrumentation of higher alcohol intake using these variants recapitulated known associations of alcohol intake with hypertension. Using self-reported alcohol flushing as an instrument gave a similar association pattern of higher alcohol intake and cardiovascular disease-related traits (e.g. stroke).
Conclusion This study confirms that ALDH2-rs671 and ADH1B-rs1229984 are associated with alcohol flushing in East Asian populations. Our findings also suggest that self-reported alcohol flushing can be used as an instrumental variable in future studies of alcohol consumption.
Trial registration This study only used secondary data.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
China Kadoorie Biobank was supported as follows: Baseline survey and first re-survey: Hong Kong Kadoorie Charitable Foundation; long-term follow-up and second re-survey: UK Wellcome Trust (212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z), National Natural Science Foundation of China (91846303), and National Key Research and Development Program of China (2016YFC 0900500, 0900501, 0900504, 1303904). DNA extraction and genotyping: GlaxoSmithKline, UK Medical Research Council (MC_PC_13049, MC-PC-14135). The UK Medical Research Council (MC_UU_00017/1, MC_UU_12026/2 MC_U137686851), Cancer Research UK (C16077/A29186; C500/A16896) and the British Heart Foundation (CH/1996001/9454) provide core funding to the Clinical Trial Service Unit and Epidemiological Studies Unit at Oxford University for the project. GH is funded by the Wellcome Trust (208806/Z/17/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The datasets analysed during the current study are not openly available due to institutional restrictions regarding accessibility, but are available from the corresponding author on reasonable request and with permission of the committee of CKB and KoGES.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets analysed during the current study are not publicly available due to institutional restrictions regarding accessibility, but are available from the corresponding author on reasonable request and with permission of the committee of CKB and KoGES.
LIST OF ABBREVIATIONS
- ALDH2
- Aldehyde dehydrogenase 2
- ADH1B
- Alcohol dehydrogenase 1B
- GWAS
- Genome-wide association studies
- IV
- Instrumental variable
- CKB
- China Kadoorie Biobank
- KoGES
- Korean Genome and Epidemiology Study
- PCs
- Principal components
- SE
- Standard errors
- OR
- Odds ratios
- quantile-quantile
- SD
- Standard deviation
- AST
- Aspartate aminotransferase
- GGT
- Gamma-glutamyl transferase
- BP
- Blood pressure
- DBP
- Diastolic blood pressure
- SBP
- Systolic blood pressure
